BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 22364398)

  • 21. Bone morphogenetic protein signaling is impaired in an HFE knockout mouse model of hemochromatosis.
    Corradini E; Garuti C; Montosi G; Ventura P; Andriopoulos B; Lin HY; Pietrangelo A; Babitt JL
    Gastroenterology; 2009 Oct; 137(4):1489-97. PubMed ID: 19591830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Downregulation of BMP6 enhances cell proliferation and chemoresistance via activation of the ERK signaling pathway in breast cancer.
    Lian WJ; Liu G; Liu YJ; Zhao ZW; Yi T; Zhou HY
    Oncol Rep; 2013 Jul; 30(1):193-200. PubMed ID: 23674072
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rat Osteosarcoma Cells as a Therapeutic Target Model for Osteoregeneration via Sclerostin Knockdown.
    Sedaghati B; Jahroomishirazi R; Starke A; Hacker MC; Schulz-Siegmund M
    Cells Tissues Organs; 2016; 201(5):366-79. PubMed ID: 27233518
    [TBL] [Abstract][Full Text] [Related]  

  • 24. BMP/Smad signaling is not enhanced in Hfe-deficient mice despite increased Bmp6 expression.
    Kautz L; Meynard D; Besson-Fournier C; Darnaud V; Al Saati T; Coppin H; Roth MP
    Blood; 2009 Sep; 114(12):2515-20. PubMed ID: 19622835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The deubiquitinating enzyme PSMD14 facilitates tumor growth and chemoresistance through stabilizing the ALK2 receptor in the initiation of BMP6 signaling pathway.
    Seo D; Jung SM; Park JS; Lee J; Ha J; Kim M; Park SH
    EBioMedicine; 2019 Nov; 49():55-71. PubMed ID: 31685442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of noggin in human mesenchymal stem cell differentiation.
    Rifas L
    J Cell Biochem; 2007 Mar; 100(4):824-34. PubMed ID: 17133353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endogenous bone morphogenetic protein-7 controls the motility of prostate cancer cells through regulation of bone morphogenetic protein antagonists.
    Ye L; Lewis-Russell JM; Kynaston H; Jiang WG
    J Urol; 2007 Sep; 178(3 Pt 1):1086-91. PubMed ID: 17644136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BMP10 as a potent inducer of trophoblast differentiation in human embryonic and induced pluripotent stem cells.
    Lichtner B; Knaus P; Lehrach H; Adjaye J
    Biomaterials; 2013 Dec; 34(38):9789-802. PubMed ID: 24070570
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sclerostin inhibition of Wnt-3a-induced C3H10T1/2 cell differentiation is indirect and mediated by bone morphogenetic proteins.
    Winkler DG; Sutherland MS; Ojala E; Turcott E; Geoghegan JC; Shpektor D; Skonier JE; Yu C; Latham JA
    J Biol Chem; 2005 Jan; 280(4):2498-502. PubMed ID: 15545262
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostate cancer induces bone metastasis through Wnt-induced bone morphogenetic protein-dependent and independent mechanisms.
    Dai J; Hall CL; Escara-Wilke J; Mizokami A; Keller JM; Keller ET
    Cancer Res; 2008 Jul; 68(14):5785-94. PubMed ID: 18632632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BMP activated Smad signaling strongly promotes migration and invasion of hepatocellular carcinoma cells.
    Maegdefrau U; Bosserhoff AK
    Exp Mol Pathol; 2012 Feb; 92(1):74-81. PubMed ID: 22024355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone morphogenetic proteins differentially regulate pigmentation in human skin cells.
    Singh SK; Abbas WA; Tobin DJ
    J Cell Sci; 2012 Sep; 125(Pt 18):4306-19. PubMed ID: 22641693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Temporal and spatial expression profiles of BMP receptors and noggin during BMP-2-induced ectopic bone formation.
    Nakamura Y; Wakitani S; Nakayama J; Wakabayashi S; Horiuchi H; Takaoka K
    J Bone Miner Res; 2003 Oct; 18(10):1854-62. PubMed ID: 14584896
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of sclerostin expression by mechanical loading and bone morphogenetic proteins in osteogenic cells.
    Papanicolaou SE; Phipps RJ; Fyhrie DP; Genetos DC
    Biorheology; 2009; 46(5):389-99. PubMed ID: 19940355
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Promoter methylation of the bone morphogenetic protein 6 gene in multiple myeloma.
    Hashida Y; Nemoto Y; Imajoh M; Murakami M; Taniguchi A; Komatsu N; Yokoyama A; Daibata M
    Oncol Rep; 2012 Mar; 27(3):825-30. PubMed ID: 22086350
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BMP6 Regulates Corneal Epithelial Cell Stratification by Coordinating Their Proliferation and Differentiation and Is Upregulated in Pterygium.
    Tiwari A; Swamynathan S; Campbell G; Jhanji V; Swamynathan SK
    Invest Ophthalmol Vis Sci; 2020 Aug; 61(10):46. PubMed ID: 32845956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of TMPRSS6 by BMP6 and iron in human cells and mice.
    Meynard D; Vaja V; Sun CC; Corradini E; Chen S; López-Otín C; Grgurevic L; Hong CC; Stirnberg M; Gütschow M; Vukicevic S; Babitt JL; Lin HY
    Blood; 2011 Jul; 118(3):747-56. PubMed ID: 21622652
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of the BMP signaling antagonist noggin in the development of prostate cancer osteolytic bone metastasis.
    Secondini C; Wetterwald A; Schwaninger R; Thalmann GN; Cecchini MG
    PLoS One; 2011 Jan; 6(1):e16078. PubMed ID: 21249149
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of noggin interference in a rabbit posterolateral spinal fusion model.
    Klineberg E; Haudenschild DR; Snow KD; Garitty S; Christiansen BA; Acharya C; Maitra S; Gupta MC
    Eur Spine J; 2014 Nov; 23(11):2385-92. PubMed ID: 24740279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The BMP antagonist Noggin is produced by osteoblasts in response to the presence of prostate cancer cells.
    AlShaibi HF; Ahmed F; Buckle C; Fowles ACM; Awlia J; Cecchini MG; Eaton CL
    Biotechnol Appl Biochem; 2018 May; 65(3):407-418. PubMed ID: 28981962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.